UK-CAB 72: COVID-19 and CD4/immune system; CROI feedback and London patient
Thursday 30 April 2020 – Zoom meeting
- Registration
- Meeting venue – webinar details to follow
- Expenses
Programme
| 09.45 | Webinar is open |
| 10.00-10:45 | Impact of COVID-19 on CD4/immune system – Dr Laura Waters, Mortimer Market Centre |
| 10:45-10:55 | BREAK |
| 10:55-11.55 | CROI feedback – Simon Collins |
| 11.55-12.55 | Special guest: London patient – Q&A |
| 13.00 | Meeting close |
Slides and meeting report
- Impact of COVID-19 on CD4/immune system
- CROI Feedback
- Webinar video (to follow)
Background reading
Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year.
This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering. The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.
Next Post